![]() |
市场调查报告书
商品编码
1954597
全球牙科骨移植市场:市场规模、占有率、成长率、行业分析、依类型、应用和地区划分的分析以及未来预测(2026-2034年)Dental Bone Graft Substitutes Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025年全球牙科骨移植市场价值为 3.2814亿美元,预计2026年将成长至 3.5025亿美元。预计到2034年,该市场将达到 6.1203亿美元,在预测期(2026-2034年)内年复合成长率(CAGR)为 7.23%。
2025年,北美以 47.93%的市场占有率引领全球市场,这得益于大量的牙科植牙手术、骨损伤病例的增加以及强大的产品创新能力。
牙科替代骨移植材料是指用于牙科治疗的天然或合成材料。用于修復或再生受损骨组织。这些产品包括同种异体移植骨、合成骨移植骨、脱矿骨基质(DBM)和异种移植骨,广泛应用于植牙和牙周病治疗。
市场概览及成长因素
牙科疾病的日益增多是市场成长的主要驱动力。根据世界卫生组织(WHO)统计,全球有 5.14亿儿童患有乳牙龋齿,200万成年人患有恆牙龋齿。牙周病、牙齿断裂和牙齿脱落病例的增加,加速了对植牙的需求,并增加了对替代性骨移植材料的需求。
此外,先进产品的推出、病患意识的提高以及研发投入的增加,都促进了市场扩张。策略联盟、收购和融资措施进一步推动创新和产品上市。
2020年,受新冠疫情相关的诊所关闭和治疗限制的影响,市场出现萎缩。但2021年,随着牙科诊所重新开放、远距牙科的扩展以及植牙手术的增加,市场开始復苏。预计这一强劲的成长趋势将持续到2034年。
市场趋势
3D列印合成骨移植的兴起
最重要的趋势之一是3D列印合成骨移植的应用。这些移植材料能够忠实地复製天然骨骼的结构,具有更好的生物相容性和长期的治疗效果。技术进步使得根据每位患者的个别情况客製化移植材料的设计成为可能。
例如,2022年12月,Desktop Metal公司的牙科3D列印再生骨移植材料 "CMFlex" 获得FDA批准。随着监管审批的增加和技术创新,预计这一趋势将进一步增强。
市场成长因素
先进替代骨移植材料的推出
随着需要颚骨稳定的牙科植牙手术数量不断增加,对创新移植材料的需求也在增加。
这些发展预计将加速全球产品的普及。
策略性收购与合作
收购与合作增强市场渗透率。例如,Biocomposits 于2023年 6月收购了 Altos,扩展了其在牙科领域的骨移植材料产品组合。製造商与牙科服务机构(DSO)之间的合作也有助于产品的供应和分销。
限制因子
儘管成长前景强劲,但仍存在挑战。临床限制、疾病传播担忧、免疫原性、骨形成不足以及严格的监管要求可能会限制产品的普及。此外,一些国家有限的保险覆盖范围可能会增加患者的自付费用,抑制需求。
依产品类型
市场依产品类型细分为同种异体移植、合成骨移植、去矿骨基质及异种移植。
依形状划分
该市场包括颗粒、糊剂和其他形状。
依最终使用者划分
市场细分包括个人执业者、牙科服务机构/集团诊所和其他。
北美
北美市场在2025年达到1.5688亿美元,在2026年将达到1.6786亿美元。光是美国市场预计在2026年就将达到1.5204亿美元。强劲的创新、FDA的批准以及大量的植入手术推动市场成长。
欧洲
欧洲占第二大市场。
策略性收购和研发投资推动市场扩张。
亚太地区
预计亚太地区将纪录最高的市场占有率。年复合成长率(CAGR)
成长主要受人口老化和牙科疾病盛行率上升的驱动。
拉丁美洲、中东和非洲地区
这些地区的成长主要受医疗基础设施改善、公众意识提高和医疗旅游业发展所驱动。
The global dental bone graft substitutes market was valued at USD 328.14 million in 2025 and is projected to grow to USD 350.25 million in 2026. The market is expected to reach USD 612.03 million by 2034, exhibiting a CAGR of 7.23% during the forecast period (2026-2034).
North America dominated the global market with a 47.93% share in 2025, driven by a high number of dental implant procedures, rising cases of bone injuries, and strong product innovation.
Dental bone graft substitutes are natural or synthetic materials used to repair or regenerate damaged bone tissue in dental procedures. These products include allografts, synthetic bone substitutes, demineralized bone matrix (DBM), and xenografts, and are widely used in implant dentistry and periodontal treatments.
Market Overview & Growth Drivers
The rising prevalence of dental disorders is a key factor driving market growth. According to the World Health Organization (WHO), 514 million children suffer from primary tooth decay, while 2 million adults are affected by permanent tooth decay globally. Increasing cases of periodontal disease, dental fractures, and tooth loss have accelerated demand for dental implants, thereby increasing the need for bone graft substitutes.
Additionally, the introduction of advanced products, growing awareness among patients, and increased R&D investments are contributing to market expansion. Strategic collaborations, acquisitions, and funding initiatives are further supporting innovation and product adoption.
Although the market declined in 2020 due to COVID-19-related clinic closures and restricted procedures, recovery began in 2021 with reopening of dental practices, increasing tele-dentistry adoption, and rising implant surgeries. The positive growth trend is expected to continue through 2034.
Market Trends
Rise of 3D-Printed Synthetic Bone Grafts
One of the most significant trends is the adoption of 3D-printed synthetic bone graft substitutes. These grafts closely mimic natural bone structure and enable better integration and long-term outcomes. Technological advancements allow customized graft design tailored to individual patients.
For example, in December 2022, Desktop Metal received U.S. FDA approval for its CMFlex 3D-printed regenerative bone graft for dental use. Increasing regulatory approvals and technological innovations are expected to further strengthen this trend.
Market Growth Factors
Introduction of Advanced Bone Graft Substitutes
The growing number of dental implant procedures requiring jawbone stabilization has increased demand for innovative graft materials.
Such developments are expected to accelerate product adoption globally.
Strategic Acquisitions & Partnerships
Acquisitions and collaborations are strengthening market penetration. For instance, Biocomposites acquired Artoss in June 2023, expanding its bone graft portfolio in dentistry. Partnerships between manufacturers and dental service organizations (DSOs) are also boosting accessibility and product distribution.
Restraining Factors
Despite strong growth prospects, challenges remain. Clinical limitations, concerns about disease transmission, immunogenicity, inadequate bone formation, and strict regulatory requirements can limit adoption. Additionally, limited reimbursement coverage in several countries increases out-of-pocket expenses for patients, potentially restricting demand.
By Product Type
The market is segmented into allografts, synthetic substitutes, demineralized bone matrix, and xenografts.
By Form
The market includes granules, putty, and others.
By End-User
The market is segmented into solo practices, DSO/group practices, and others.
North America
North America recorded USD 156.88 million in 2025 and is projected to reach USD 167.86 million in 2026. The U.S. market alone is expected to reach USD 152.04 million in 2026. Strong innovation, FDA approvals, and high implant volumes support growth.
Europe
Europe held the second-largest market share.
Strategic acquisitions and R&D investments are driving expansion.
Asia Pacific
Asia Pacific is projected to register the highest CAGR.
Growth is fueled by rising geriatric population and increasing dental disorder prevalence.
Latin America & Middle East & Africa
Growth in these regions is driven by improving healthcare infrastructure, growing awareness, and increasing medical tourism.
Competitive Landscape
Key players include ZimVie Inc., Medtronic, Geistlich Pharma AG, Institut Straumann AG, Envista, Dentsply Sirona, Henry Schein, NovaBone, BioHorizons, botiss biomaterials GmbH, and others.
These companies focus on R&D, product launches, acquisitions, and geographical expansion to strengthen their market positions.
Conclusion
The global dental bone graft substitutes market is poised for steady growth, expanding from USD 328.14 million in 2025 to USD 612.03 million by 2034, driven by increasing dental implant procedures, technological advancements such as 3D-printed grafts, and strong regional innovation. North America remains the dominant market, while Asia Pacific is emerging as the fastest-growing region. Despite reimbursement and clinical challenges, rising R&D investments and strategic collaborations are expected to ensure sustained market expansion through 2034.
Segmentation By Product Type
By Form
By End-user
By Regin